Variant report

Variant	nsv585724
Chromosome Location	chr20:23642427-23721992
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr20:23649147-23649450	HepG2	liver:	n/a	n/a
2	ARID3A	chr20:23640739-23642649	HepG2	liver:	n/a	n/a
3	BRCA1	chr20:23649179-23649335	HepG2	liver:	n/a	n/a
4	CEBPB	chr20:23710540-23710875	HepG2	liver:	n/a	chr20:23710701-23710712
5	CEBPB	chr20:23710550-23710870	IMR90	lung:	n/a	chr20:23710701-23710712
6	CEBPB	chr20:23642025-23642637	HepG2	liver:	n/a	chr20:23642317-23642328
7	CEBPB	chr20:23641818-23642580	HepG2	liver:	n/a	chr20:23642317-23642328
8	CEBPB	chr20:23642081-23642475	HepG2	liver:	n/a	chr20:23642317-23642328
9	CEBPB	chr20:23715126-23715326	A549	lung:	n/a	chr20:23715271-23715282
10	CEBPB	chr20:23655411-23655454	HepG2	liver:	n/a	n/a
11	CEBPB	chr20:23641985-23642627	HepG2	liver:	n/a	chr20:23642317-23642328
12	CEBPB	chr20:23687994-23688164	IMR90	lung:	n/a	chr20:23688059-23688070
13	CEBPB	chr20:23710539-23710875	A549	lung:	n/a	chr20:23710701-23710712
14	CEBPB	chr20:23687909-23688202	HepG2	liver:	n/a	chr20:23688059-23688070
15	CEBPB	chr20:23642178-23642466	A549	lung:	n/a	chr20:23642317-23642328
16	CEBPB	chr20:23684405-23684588	HepG2	liver:	n/a	chr20:23684504-23684515 chr20:23684504-23684517 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684517 chr20:23684506-23684515
17	CEBPB	chr20:23687946-23688194	A549	lung:	n/a	chr20:23688059-23688070
18	CEBPB	chr20:23710603-23710866	H1-hESC	embryonic stem cell:	n/a	chr20:23710701-23710712
19	CEBPB	chr20:23715136-23715338	IMR90	lung:	n/a	chr20:23715271-23715282
20	CEBPB	chr20:23684500-23684595	A549	lung:	n/a	chr20:23684504-23684515 chr20:23684504-23684517 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684515 chr20:23684506-23684517 chr20:23684506-23684515
21	CEBPB	chr20:23642261-23642432	Hela-S3	cervix:	n/a	chr20:23642317-23642328
22	CEBPB	chr20:23715133-23715386	HepG2	liver:	n/a	chr20:23715271-23715282
23	CEBPB	chr20:23710656-23710785	K562	blood:	n/a	chr20:23710701-23710712
24	CEBPD	chr20:23642088-23642679	HepG2	liver:	n/a	chr20:23642316-23642327
25	CEBPD	chr20:23642124-23642620	HepG2	liver:	n/a	chr20:23642316-23642327
26	CHD1	chr20:23648812-23649497	IMR90	lung:	n/a	n/a
27	CHD2	chr20:23649131-23649258	HepG2	liver:	n/a	n/a
28	CHD2	chr20:23642088-23642521	HepG2	liver:	n/a	n/a
29	CHD2	chr20:23649288-23649303	GM12878	blood:	n/a	n/a
30	CHD2	chr20:23643986-23644012	HepG2	liver:	n/a	n/a
31	CTCF	chr20:23648943-23649682	HCT-116	colon:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
32	CTCF	chr20:23704340-23704899	Gliobla	brain:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704741-23704757 chr20:23704742-23704763 chr20:23704496-23704505 chr20:23704787-23704796 chr20:23704740-23704758
33	CTCF	chr20:23649067-23649575	GM10266	blood:	n/a	chr20:23649448-23649464 chr20:23649447-23649465 chr20:23649201-23649222 chr20:23649449-23649470 chr20:23649199-23649217 chr20:23649200-23649216
34	CTCF	chr20:23704377-23704634	Hela-S3	cervix:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
35	CTCF	chr20:23704360-23704510	GM12864	blood:	n/a	chr20:23704496-23704505
36	CTCF	chr20:23646940-23647090	HMF	breast:	n/a	chr20:23646995-23647008 chr20:23646993-23647011 chr20:23646988-23647009
37	CTCF	chr20:23649120-23649270	HEEpiC	esophagus:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
38	CTCF	chr20:23704191-23704227	GM19240	blood:	n/a	n/a
39	CTCF	chr20:23667760-23667910	GM12867	blood:	n/a	n/a
40	CTCF	chr20:23646872-23647167	H1-hESC	embryonic stem cell:	n/a	chr20:23646995-23647008 chr20:23646993-23647011 chr20:23646988-23647009
41	CTCF	chr20:23704340-23704490	HMEC	breast:	n/a	n/a
42	CTCF	chr20:23646920-23647070	SK-N-SH_RA	brain:	n/a	chr20:23646995-23647008 chr20:23646993-23647011 chr20:23646988-23647009
43	CTCF	chr20:23646920-23647070	HMEC	breast:	n/a	chr20:23646995-23647008 chr20:23646993-23647011 chr20:23646988-23647009
44	CTCF	chr20:23704340-23704490	GM06990	blood:	n/a	n/a
45	CTCF	chr20:23704380-23704530	NHDF-neo	bronchial:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
46	CTCF	chr20:23704300-23704674	IMR90	lung:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
47	CTCF	chr20:23648440-23648590	GM06990	blood:	n/a	n/a
48	CTCF	chr20:23704378-23704661	Medullo	brain:	n/a	chr20:23704495-23704516 chr20:23704493-23704511 chr20:23704496-23704505
49	CTCF	chr20:23649077-23649344	Fibrobl	skin:	n/a	chr20:23649201-23649222 chr20:23649199-23649217 chr20:23649200-23649216
50	CTCF	chr20:23646860-23647010	GM12868	blood:	n/a	chr20:23646995-23647008 chr20:23646988-23647009

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:23669470-23669520	HCM	heart:	n/a
2	chr20:23669470-23669520	HCM	heart:	n/a
3	chr20:23670089-23670139	NH-A	brain:	n/a
4	chr20:23671108-23671158	HUVEC	blood vessel:	n/a
5	chr20:23669241-23669291	GM12891	blood:	n/a
6	chr20:23670047-23670097	BJ	skin:	n/a
7	chr20:23666505-23666555	HRE	kidney:	n/a
8	chr20:23669470-23669520	GM06990	blood:	n/a
9	chr20:23670047-23670097	Caco-2	colon:	n/a
10	chr20:23669241-23669291	BE2_C	brain:	n/a
11	chr20:23666505-23666555	HRCEpiC	kidney:	n/a
12	chr20:23666505-23666555	GM19239	blood:	n/a
13	chr20:23666505-23666555	A549	lung:	n/a
14	chr20:23670089-23670139	HAEpiC	amniotic membrane:	n/a
15	chr20:23670047-23670097	SK-N-SH	brain:	n/a
16	chr20:23670089-23670139	NHBE	bronchial:	n/a
17	chr20:23670089-23670139	HCT-116	colon:	n/a
18	chr20:23669241-23669291	H1-hESC	embryonic stem cell:	embryo
19	chr20:23671108-23671158	PFSK-1	brain:	n/a
20	chr20:23671108-23671158	Hela-S3	cervix:	n/a
21	chr20:23666505-23666555	HUVEC	blood vessel:	n/a
22	chr20:23671108-23671158	HMEC	breast:	n/a
23	chr20:23666505-23666555	T-47D	breast:	n/a
24	chr20:23666505-23666555	HRPEpiC	eye:	n/a
25	chr20:23670047-23670097	AG04449	skin:	fetal
26	chr20:23666505-23666555	GM12891	blood:	n/a
27	chr20:23670047-23670097	AG10803	skin:	n/a
28	chr20:23671108-23671158	BE2_C	brain:	n/a
29	chr20:23666505-23666555	Hela-S3	cervix:	n/a
30	chr20:23670047-23670097	BE2_C	brain:	n/a
31	chr20:23669241-23669291	HCPEpiC	choroid plexus:	n/a
32	chr20:23670047-23670097	SK-N-SH_RA	brain:	n/a
33	chr20:23670047-23670097	GM12878	blood:	n/a
34	chr20:23670089-23670139	HEEpiC	esophagus:	n/a
35	chr20:23669470-23669520	HEEpiC	esophagus:	n/a
36	chr20:23666505-23666555	ovcar-3	ovarian:	n/a
37	chr20:23669470-23669520	HCPEpiC	choroid plexus:	n/a
38	chr20:23670089-23670139	K562	blood:	n/a
39	chr20:23671108-23671158	BJ	skin:	n/a
40	chr20:23671108-23671158	RPTEC	kidney:	n/a
41	chr20:23670047-23670097	HCM	heart:	n/a
42	chr20:23669470-23669520	HAEpiC	amniotic membrane:	n/a
43	chr20:23670047-23670097	SKMC	muscle:	n/a
44	chr20:23669470-23669520	GM12892	blood:	n/a
45	chr20:23670089-23670139	NHDF-neo	bronchial:	n/a
46	chr20:23669241-23669291	ProgFib	skin:	n/a
47	chr20:23670047-23670097	HCPEpiC	choroid plexus:	n/a
48	chr20:23670089-23670139	IMR90	lung:	fetal
49	chr20:23670089-23670139	PANC-1	pancreas:	n/a
50	chr20:23669470-23669520	HUVEC	blood vessel:	n/a

No.	Distal block	Cell Line	Cell type
1	chr20:23648954..23649672-chr20:23703387..23704074,2	MCF-7	breast:
2	chr20:23648334..23649447-chr20:23704109..23705001,3	MCF-7	breast:
3	chr20:23645187..23645712-chr20:23775888..23776677,2	MCF-7	breast:
4	chr20:23649611..23652412-chr20:23660454..23663208,2	MCF-7	breast:
5	chr20:23649611..23652412-chr20:23660454..23663208,2	MCF-7	breast:
6	chr20:23704352..23705295-chr20:23754423..23755304,4	MCF-7	breast:
7	chr20:23648954..23649672-chr20:23703387..23704074,2	MCF-7	breast:
8	chr20:23704490..23705249-chr20:23762654..23763235,2	MCF-7	breast:
9	chr20:23702805..23703439-chr20:23754485..23755364,2	MCF-7	breast:
10	chr20:23704491..23705478-chr20:23779622..23780975,4	MCF-7	breast:
11	chr20:23648665..23649293-chr20:23837547..23838405,2	MCF-7	breast:
12	chr20:23649188..23649689-chr20:23762769..23763504,2	MCF-7	breast:
13	chr20:23648920..23650143-chr20:23704363..23705222,5	MCF-7	breast:
14	chr20:23648842..23649774-chr20:23870335..23871266,4	MCF-7	breast:
15	chr20:23648767..23649721-chr20:23779902..23780425,2	MCF-7	breast:
16	chr20:23648920..23650143-chr20:23704363..23705222,5	MCF-7	breast:
17	chr20:23648334..23649447-chr20:23704109..23705001,3	MCF-7	breast:

Variant related genes	Relation type
CST4	TF binding region
CST2P1	TF binding region
CST4	CpG island
CST2P1	CpG island

Extended variants
information (count: 2942 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:2942 , 50 per page) page: 1 2 3 4 5 6 7 ... 59

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs16985615	chr20:23642427-23642428	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance disease
2	rs530705608	chr20:23642431-23642432	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs185542633	chr20:23642445-23642446	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs560851460	chr20:23642457-23642458	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs3004153	chr20:23642458-23642459	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs189615149	chr20:23642466-23642467	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs566413505	chr20:23642469-23642470	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs6048975	chr20:23642477-23642478	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs532259921	chr20:23642501-23642502	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs551873288	chr20:23642530-23642531	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs568915939	chr20:23642570-23642571	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs182300474	chr20:23642613-23642614	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs73318186	chr20:23642616-23642617	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs189007417	chr20:23642648-23642649	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs534100536	chr20:23642718-23642719	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs193146973	chr20:23642739-23642740	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs536723971	chr20:23642752-23642753	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs150369081	chr20:23642759-23642760	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs138105220	chr20:23642773-23642774	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs184056657	chr20:23642783-23642784	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs575980377	chr20:23642785-23642786	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs2983608	chr20:23642839-23642840	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
23	rs142336384	chr20:23642855-23642856	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs574412459	chr20:23642856-23642857	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs565617247	chr20:23642873-23642874	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs369530297	chr20:23642915-23642916	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs146460806	chr20:23642942-23642943	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs6106692	chr20:23642973-23642974	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs188208449	chr20:23642983-23642984	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs569899974	chr20:23642996-23642997	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs552299438	chr20:23643023-23643024	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs6106693	chr20:23643037-23643038	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs139035625	chr20:23643061-23643062	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs531293901	chr20:23643086-23643087	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs34703610	chr20:23643102-23643103	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs199607164	chr20:23643116-23643117	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs369649262	chr20:23643120-23643121	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs373564950	chr20:23643121-23643122	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs548225559	chr20:23643173-23643174	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs533965475	chr20:23643185-23643186	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs143063476	chr20:23643192-23643193	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs192215740	chr20:23643204-23643205	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs143717378	chr20:23643232-23643233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs571071486	chr20:23643242-23643243	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs539648631	chr20:23643259-23643260	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs556197506	chr20:23643267-23643268	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs576141352	chr20:23643292-23643293	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs535428075	chr20:23643344-23643345	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs555368418	chr20:23643364-23643365	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs116186133	chr20:23643372-23643373	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
small cell lung cancer	17426248	CNVD
Breast cancer	21364760	CNVD
Gastric cancer	22014070	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:234 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23637200-23643600	Weak transcription	Right Atrium	heart
2	chr20:23637200-23660000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr20:23637800-23644200	Enhancers	Fetal Intestine Large	intestine
4	chr20:23638400-23644200	Enhancers	Fetal Intestine Small	intestine
5	chr20:23639400-23643200	Flanking Active TSS	HepG2	liver
6	chr20:23639800-23643400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr20:23640000-23642600	Enhancers	Duodenum Mucosa	Duodenum
8	chr20:23641200-23643000	Weak transcription	Fetal Muscle Trunk	muscle
9	chr20:23641400-23642600	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr20:23641800-23643000	Weak transcription	Fetal Muscle Leg	muscle
11	chr20:23641800-23647000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
12	chr20:23641800-23647200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr20:23641800-23647200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr20:23641800-23652200	Weak transcription	Adipose Nuclei	Adipose
15	chr20:23642000-23642600	Enhancers	Primary monocytes fromperipheralblood	blood
16	chr20:23642200-23642600	Enhancers	Rectal Mucosa Donor 31	rectum
17	chr20:23642200-23642600	Enhancers	Monocytes-CD14+_RO01746	blood
18	chr20:23642400-23644800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
19	chr20:23642400-23649400	Weak transcription	Skeletal Muscle Male	skeletal muscle
20	chr20:23642600-23647000	Weak transcription	Primary monocytes fromperipheralblood	blood
21	chr20:23642600-23647000	Weak transcription	Monocytes-CD14+_RO01746	blood
22	chr20:23643000-23643200	Enhancers	Esophagus	oesophagus
23	chr20:23643000-23643200	Enhancers	Fetal Muscle Leg	muscle
24	chr20:23643000-23644000	Enhancers	Fetal Muscle Trunk	muscle
25	chr20:23643200-23643600	Weak transcription	Fetal Muscle Leg	muscle
26	chr20:23643200-23644200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr20:23643200-23646000	Enhancers	HepG2	liver
28	chr20:23643400-23646800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr20:23643600-23643800	Enhancers	Fetal Muscle Leg	muscle
30	chr20:23643800-23647800	Weak transcription	Fetal Muscle Leg	muscle
31	chr20:23644000-23644200	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
32	chr20:23644000-23648400	Weak transcription	Fetal Muscle Trunk	muscle
33	chr20:23644800-23645000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr20:23644800-23645400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr20:23645000-23645600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
36	chr20:23645400-23646200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr20:23645600-23645800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
38	chr20:23645800-23646000	Enhancers	Spleen	Spleen
39	chr20:23645800-23647000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
40	chr20:23646000-23647000	Weak transcription	Spleen	Spleen
41	chr20:23646000-23649200	Weak transcription	HepG2	liver
42	chr20:23646800-23647200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr20:23647000-23647200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr20:23647000-23647600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
45	chr20:23647000-23647600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
46	chr20:23647000-23647600	Enhancers	Monocytes-CD14+_RO01746	blood
47	chr20:23647000-23647800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr20:23647000-23648000	Enhancers	Primary monocytes fromperipheralblood	blood
49	chr20:23647000-23648000	Enhancers	Cortex derived primary cultured neurospheres	brain
50	chr20:23647000-23648000	Enhancers	HUVEC	blood vessel

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links